|
CN105147624A
|
|
Esomeprazole sodium for injection and preparation method thereof
|
|
CN105078912A
|
|
Ademetionine for injection and preparation method thereof
|
|
CN105125506A
|
|
Parecoxib sodium for injection and preparing method of parecoxib sodium for injection
|
|
CN104749288A
|
|
Liquid chromatographic analysis method for parecoxib-sodium related substances
|
|
CN104147602A
|
|
Composition for improving dissolution rate of benzamide gastric motility drug and application of composition
|
|
CN104341392A
|
|
Novel esomeprazole sodium crystal form, preparing method thereof and applications of the crystal form
|
|
CN103239447A
|
|
Storage-stable lansoprazole composition for injection
|
|
WO2012171443A1
|
|
Dry powder drug administration device
|
|
CN103087091A
|
|
L-alpha-choline glycerophosphate synthesis method
|
|
CN102228725A
|
|
Dry powder administration device
|
|
CN102218182A
|
|
Vibrating dosing device for dry power dosing device
|
|
CN102375037A
|
|
Method for separating and determining pregabalin chiral isomer with electrophoretically mediated microanalysis technology
|
|
CN102453029A
|
|
Novel crystal of paliperidone and preparation method thereof
|
|
CN102199143A
|
|
New preparation method for crystal with imatinibmesylate alpha crystal form
|
|
CN101991555A
|
|
Quetiapine fumarate tablet and preparation method thereof
|
|
CN101991570A
|
|
Stable compound keto acid preparation and preparation method thereof
|
|
CN101987094A
|
|
Ornithine aspartate injection and preparation method thereof
|
|
CN101987099A
|
|
Omeprazole sodium for injection and preparation method thereof
|
|
CN101987858A
|
|
New method for preparing decitabine beta-configuration intermediate
|
|
CN101987090A
|
|
Fluoxetine capsule and preparation method thereof
|
